Table 2.
Age- and sex-specific and age-adjusted prevalence of metabolic syndrome based on definitions of the JIS, the IDF, and the ATPIII (n = 947)
| Age-group (years) | n | Metabolic syndrome |
||
|---|---|---|---|---|
| JIS | IDF | ATPIII | ||
| Men (n = 189) | ||||
| 15–24 | 44 | 0.0 (0) | 0.0 (0) | 0.0 (0) |
| 25–34 | 20 | 5.0 (1) | 10.0 (2) | 5.0 (1) |
| 35–44 | 22 | 13.6 (3) | 13.6 (3) | 4.5 (1) |
| 45–54 | 28 | 25.0 (7) | 25.0 (7) | 21.4 (6) |
| 55–64 | 31 | 12.9 (4) | 12.9 (4) | 12.9 (4) |
| ≥65 | 44 | 15.9 (7) | 13.6 (6) | 11.4 (5) |
| Total crude | 189 | 11.6 (22) | 11.6 (22) | 9.0 (17) |
| Age adjusted | — | 10.5 | 11.2 | 7.9 |
| Women (n = 758) | ||||
| 15–24 | 101 | 5.9 (6) | 4.0 (4) | 4.0 (4) |
| 25–34 | 123 | 16.3 (20) | 12.2 (15) | 6.5 (8) |
| 35–44 | 149 | 26.2 (39) | 22.8 (34) | 17.4 (26) |
| 45–54 | 106 | 39.6 (42) | 33.0 (35) | 28.3 (30) |
| 55–64 | 124 | 42.7 (53) | 39.5 (49) | 29.8 (37) |
| ≥65 | 154 | 44.2 (68) | 39.6 (61) | 34.4 (53) |
| Missing | 1 | 0 (1) | 0 (1) | 0 (1) |
| Total crude | 758 | 30.2 (229) | 26.3 (199) | 20.9 (158) |
| Age adjusted | — | 25.0 | 21.2 | 16.8 |
Data are % (n).